Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.

Central obesity is frequently associated with adipose tissue inflammation and hepatic insulin resistance. To identify potential individual mediators in this process, we used in vitro systems and assessed if insulin resistance in liver cells could be induced by secreted products from adipocytes preexposed to an inflammatory stimulus. Conditioned medium from 3T3-L1 adipocytes pretreated without (CM) or with TNFalpha (CM-TNFalpha) was used to treat Fao hepatoma cells. ELISAs were used to assess the concentration of several inflammatory mediators in CM-TNFalpha. CM-TNFalpha-treated Fao cells exhibited about 45% diminution in insulin-stimulated phosphorylation of insulin receptor, insulin receptor substrate proteins, protein kinase B, and glycogen synthase kinase-3 as compared with CM-treated cells, without changes in the total abundance of these protein. Insulin increased glycogenesis by 2-fold in CM-treated Fao cells but not in cells exposed to CM-TNFalpha. Expression of IL-1beta mRNA was elevated 3-fold in TNFalpha-treated adipocytes, and CM-TNFalpha had 10-fold higher concentrations of IL-1beta but not TNFalpha or IL-1alpha. IL-1beta directly induced insulin resistance in Fao, HepG2, and in primary rat hepatocytes. Moreover, when TNFalpha-induced secretion/production of IL-1beta from adipocytes was inhibited by the IL-1 converting enzyme (ICE-1) inhibitor II (Ac-YVAD-CMK), insulin resistance was prevented. Furthermore, liver-derived cells treated with IL-1 receptor antagonist were protected against insulin resistance induced by CM-TNFalpha. Finally, IL-1beta secretion from human omental fat explants correlated with body mass index (R(2) = 0.639, P < 0.01), and the resulting CM induced insulin resistance in HepG2 cells, inhibitable by IL-1 receptor antagonist. Our results suggest that adipocyte-derived IL-1beta may constitute a mediator in the perturbed cross talk between adipocytes and liver cells in response to adipose tissue inflammation.

[1]  P. Venieratos,et al.  High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells. , 2010, Cellular signalling.

[2]  A. Chervonsky,et al.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. , 2010, The Journal of clinical investigation.

[3]  S. Schinner,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2009 .

[4]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[5]  H. Tilg,et al.  Insulin resistance, inflammation, and non-alcoholic fatty liver disease , 2008, Trends in Endocrinology & Metabolism.

[6]  E. Verna,et al.  Role of Fatty Acids in the Pathogenesis of Obesity and Fatty Liver: Impact of Bariatric Surgery , 2008, Seminars in liver disease.

[7]  L. Ivashkiv,et al.  TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes , 2008, Nature Immunology.

[8]  A. Kotronen,et al.  Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  J. Yudkin,et al.  Inflammation, Obesity, and the Metabolic Syndrome , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[10]  J. Eckel,et al.  Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes , 2007, FEBS letters.

[11]  E. Maury,et al.  Adipokines oversecreted by omental adipose tissue in human obesity. , 2007, American journal of physiology. Endocrinology and metabolism.

[12]  M. Stumvoll,et al.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[13]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[14]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[15]  S. Saadeh Nonalcoholic Fatty liver disease and obesity. , 2007, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[16]  Y. Le Marchand-Brustel,et al.  Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.

[17]  K. Clément,et al.  Review article: Is obesity an inflammatory illness? Role of low‐grade inflammation and macrophage infiltration in human white adipose tissue , 2006 .

[18]  J. Tanti,et al.  Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress , 2006, Diabetologia.

[19]  J. Capeau,et al.  Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes , 2006, Diabetologia.

[20]  J. Lv,et al.  Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. , 2006, Biochemical and biophysical research communications.

[21]  Avner Bar Hen,et al.  Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity , 2006, Diabetes.

[22]  K. Clément,et al.  Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. , 2006, BJOG : an international journal of obstetrics and gynaecology.

[23]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[24]  B. Ustundag,et al.  Proinflammatory Cytokines and Leptin Are Increased in Serum of Prepubertal Obese Children , 2005, Mediators of inflammation.

[25]  A. Syrenicz,et al.  Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. , 2005, Neuro endocrinology letters.

[26]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[27]  J. Jenkins,et al.  Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-α , 2005 .

[28]  B. Wisse,et al.  The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. , 2004, Journal of the American Society of Nephrology : JASN.

[29]  V. Giusti,et al.  Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. , 2004, The Journal of clinical endocrinology and metabolism.

[30]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[31]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[32]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[33]  R. Bergman,et al.  Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. , 2003, Diabetes.

[34]  V. Giusti,et al.  Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. , 2003, Diabetes.

[35]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[36]  H. Hauner,et al.  Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. , 2002, Diabetes.

[37]  J. Holder,et al.  Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. , 2002, Diabetes.

[38]  P. Arner Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.

[39]  M. Lane,et al.  Cross-talk between sympathetic neurons and adipocytes in coculture , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Barnett,et al.  Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  A. Rudich,et al.  Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-α in 3T3-L1 adipocytes , 2001, Diabetologia.

[42]  A. Rudich,et al.  Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.

[43]  S. Souza,et al.  BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. , 1998, Diabetes.

[44]  G. Shulman,et al.  Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.

[45]  G. Michalopoulos,et al.  Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium , 1996, The Journal of cell biology.

[46]  M. Papa,et al.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. , 1993, The Journal of biological chemistry.

[47]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[48]  D. Friend,et al.  HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, Journal of Cell Biology.